PAI Pharma Overview

  • Year Founded
  • 1968

Year Founded

  • Status
  • Private

  • Employees
  • 156

Employees

  • Latest Deal Type
  • Debt - Acquisition

  • Financing Rounds
  • 4

  • Investments
  • 3

PAI Pharma General Information

Description

Manufacturer of generic liquid pharmaceuticals intended to participate in the creation of healthier lives. The company offers oral medicines, suspensions, elixirs, syrups, unit-dose cups, and sterile injectables, enabling the healthcare sector to access high-quality and ready-to-dispense medications through vertically integrated unit-dose packaging.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 1700 Perimeter Road
  • Greenville, SC 29605
  • United States
+1 (800)
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • 1700 Perimeter Road
  • Greenville, SC 29605
  • United States
+1 (800)

PAI Pharma Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PAI Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PAI Pharma‘s full profile, request access.

Request a free trial

PAI Pharma Patents

PAI Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10251839-B2 Lipid vesicles derived from olive oil fatty acids Active 22-Jan-2008
US-20090186074-A1 Lipid vesicles derived from olive oil fatty acids Active 22-Jan-2008
CA-1241323-A Oral suspension of phenytoin Inactive 19-Oct-1982
US-4280995-A Anticonvulsants Inactive 31-Dec-1979 A61K31/715

PAI Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PAI Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PAI Pharma‘s full profile, request access.

Request a free trial

PAI Pharma Investments (3)

PAI Pharma’s most recent deal was a Buyout/LBO with Nexus Pharmaceuticals. The deal was made on 12-Nov-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Nexus Pharmaceuticals 12-Nov-2026 Buyout/LBO Pharmaceuticals
Nivagen Pharmaceuticals 06-Jan-2026 Buyout/LBO Pharmaceuticals
VistaPharm 11-Oct-2022 Buyout/LBO Pharmaceuticals
To view PAI Pharma’s complete investments history, request access »

PAI Pharma Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Nivagen Pharmaceuticals Sacramento, CA 2009
Nexus Pharmaceuticals Lincolnshire, IL 2003
VistaPharm Parsippany, NJ 1998

PAI Pharma FAQs

  • When was PAI Pharma founded?

    PAI Pharma was founded in 1968.

  • Where is PAI Pharma headquartered?

    PAI Pharma is headquartered in Greenville, SC.

  • What is the size of PAI Pharma?

    PAI Pharma has 156 total employees.

  • What industry is PAI Pharma in?

    PAI Pharma’s primary industry is Pharmaceuticals.

  • Is PAI Pharma a private or public company?

    PAI Pharma is a Private company.

  • What is PAI Pharma’s current revenue?

    The current revenue for PAI Pharma is .

  • How much funding has PAI Pharma raised over time?

    PAI Pharma has raised $110M.

  • Who are PAI Pharma’s investors?

    Apollo Global Management and Olympus Partners have invested in PAI Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process